The present invention refers to the use of hCNTF (human ciliary neurotrophic factor), mutants thereof or other molecules that activate the CNTF receptor, for the preparation of drugs for the treatment of obesity and associated disease, for example hyperglycemia. FIG. 1 shows the anti-obesity effect of hCNTF and leptin on body weight (left panels) and on food intake (right panels) in genetically obese mice and in mice with diet-induced obesity (DIO).

 
Web www.patentalert.com

< Method of producing heterocyclic derivatives

< Methods for treating neuropathic pain using heteroarylmethanesulfonamides

> Aquaporin-8 variant

> Matrix metalloprotease

~ 00072